Evidence map›Paper›PMID 42130076›Full record

ArticleCancer medicine2026

Racial, Ethnic, and Neighborhood Disparities in Acute Kidney Injury in Pediatric Acute Leukemia.

Wendy C Bravo, Yimei Li, Tamara P Miller, Kelly Getz, Lusha Cao, Edward Krause, Mark Ramos, Judy Lee, Maria Monica Gramatges, Karen R Rabin and 3 more

Abstract read
In one paragraph

Article in Cancer medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Wendy C BravoChildren's Hospital Los Angeles, Los Angeles, California, USA.ORCID https://orcid.org/0000-0002-1186-669X
Yimei LiChildren's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Tamara P MillerChildren's Healthcare of Atlanta, Atlanta, Georgia, USA.ORCID https://orcid.org/0000-0003-4250-5376
Kelly GetzChildren's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Lusha CaoChildren's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Edward KrauseChildren's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Mark RamosChildren's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Judy LeeChildren's Healthcare of Atlanta, Atlanta, Georgia, USA.
Maria Monica GramatgesTexas Children's Hospital, Houston, Texas, USA.
Karen R RabinUniversity of California San Francisco, San Francisco, California, USA.ORCID https://orcid.org/0000-0002-4081-8195
Michael ScheurerEmory University School of Medicine, Atlanta, Georgia, USA.
Richard AplencChildren's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Michelle DenburgChildren's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.

Funding

Improving Adverse Event Reporting on Cooperative Oncology Group TrialsK07CA211956 · NCI · EMORY UNIVERSITY · PI MILLER, TAMARA PORTER · 2017 to 2022
$916k
Mentoring of Early Career Researchers from Diverse BackgroundsK26DK138375 · NIDDK · CHILDREN'S HOSP OF PHILADELPHIA · PI Michelle Denburg · 2023 to 2026
$424k
Children's Hospital of Philadelphia PhilanthropyNCI NIH HHS 5K07CA211956NCI NIH HHS K07 CA211956NIDDK NIH HHS K26 DK138375NIDDK NIH HHS K26DK138375
6 · The paper itself

Abstract

introductionWe sought to identify racial/ethnic and neighborhood disparities in acute kidney injury (AKI) in children with acute lymphoblastic or myeloid leukemia (ALL, AML).

methodsElectronic health record data were retrospectively collected from patients treated for de novo pediatric ALL or AML in the multicenter Leukemia Electronic Abstraction of Records Network. AKI was defined by modified Kidney Disease Improving Global Outcomes criteria. Neighborhood-level resources were defined by the Child Opportunity Level (COL). Prevalence ratios (PRs) for AKI at diagnosis by race/ethnicity and COL were calculated using modified Poisson regression. Cox regression was used to calculate hazard ratios (HRs) of first AKI after initiation of chemotherapy (i.e., "during therapy").

resultsOf 952 ALL patients, Non-Hispanic Black (NHB) ALL patients had significantly increased prevalence of AKI at leukemia diagnosis compared to Non-Hispanic White (NHW) patients in the adjusted model (PR 1.50); there were no significant differences by COL. During ALL therapy overall, NHB patients did not have any significant differences in hazard of AKI by race/ethnicity or COL in adjusted models. Among 168 AML patients, there were no significant differences in AKI at diagnosis by race/ethnicity or COL in AML. During AML therapy overall, NHB patients had significantly higher risk of AKI in both unadjusted (HR 1.95) and adjusted (HR 2.68) models, but no differences by COL.

conclusionNHB patients with ALL had increased risk of AKI at the time of leukemia diagnosis, and NHB patients with AML had significantly increased risk of AKI during therapy. Further studies to identify drivers and interventions that mitigate AKI risk are warranted.

Indexed as

Acute Kidney InjuryHealth Status DisparitiesLeukemia, Myeloid, AcutePrecursor Cell Lymphoblastic Leukemia-LymphomaAdolescentBlack or African AmericanChildChild, PreschoolEthnicityFemaleHumansInfantMaleNeighborhood CharacteristicsPrevalenceRacial Groupsacute kidney injuryacute lymphoblastic leukemiaacute myeloid leukemiadisparitieselectronic health recordpediatric

Identifiers

PMID42130076
PMCPMC13172262

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.